Colonoscopy Clinical Trial
Official title:
A Randomized, Double-Blind, Dose-Response Study to Assess the Efficacy and Safety of AQUAVAN® Injection for Procedural Sedation in Patients Undergoing Colonoscopy
Very often, patients receive sedative medication before a diagnostic, therapeutic, or
surgical procedure to help them relax, keep them calm, and to relieve them from pain. This
is called procedural sedation. During procedural (mild to moderate) sedation, a patient is
first given a pain-relief medication (analgesic) and then a medication to help him/her relax
and keep him/her calm (sedative). Propofol is the drug commonly used for sedation because it
releases immediately into the blood stream and causes fast sedation. AQUAVAN (fospropofol
disodium) is made as a slow release version of propofol, allowing for fast sedation and
possibly faster recovery and discharge.
This study is intended to compare several different doses of AQUAVAN in patients having a
colonoscopy in order to find the right dose that will get patients to a level of mild to
moderate (procedural) sedation.
This is a randomized, double-blind study designed to evaluate the dose-response in the
sedation success rate for 4 different initial bolus doses of AQUAVAN following pretreatment
with an analgesic, fentanyl, in patients undergoing a colonoscopy. A group of patients will
receive midazolam as a reference therapy.
Following completion of pre-procedure assessments, patients will be randomly assigned to 1
of 5 IV treatment groups at an equal allocation ratio (25 patients per arm) on the day of
the scheduled procedure. Randomization will be stratified by age and ASA status:
AQUAVAN initial bolus dose 1: 8 mg/kg AQUAVAN initial bolus dose 2: 6.5 mg/kg AQUAVAN
initial bolus dose 3: 5 mg/kg AQUAVAN initial bolus dose 4: 2 mg/kg Midazolam initial bolus
dose: 0.02 mg/kg
A person skilled in airway management and authorized by the facility in which the
colonoscopy is performed (such as a respiratory therapist, a study nurse, or a clinician)
must be immediately available during the conduct of the study. All patients will be placed
on supplemental oxygen via nasal cannula (4 L/min), and a 12-lead electrocardiogram (ECG),
pulse oximeter, and blood pressure monitor prior to administration of study medication. All
patients will receive an injection of analgesic pretreatment followed by the administration
of sedative medication, as described below. This protocol recognizes 2 distinct phases of
sedation: Sedation Initiation and Sedation Maintenance. Assessments will be made to evaluate
the patients for levels of sedation, clinical benefit, and adverse events as detailed in the
protocol. Blood samples will be collected for pharmacokinetic (PK) analysis, also detailed
in the protocol.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04101097 -
Training and Validation of Models of Factors to Predict Inadequate Bowel Preparation Colonoscopy
|
||
| Completed |
NCT03247595 -
Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy
|
N/A | |
| Completed |
NCT04214301 -
An Open-Label Preference Evaluation of BLI800
|
Phase 4 | |
| Withdrawn |
NCT05754255 -
Comparison of High-flow Oxygen With or Without Nasal Positive Airway Pressure (PAP) During Propofol Sedation for Colonoscopy in an Ambulatory Surgical Center
|
N/A | |
| Recruiting |
NCT02484105 -
Comforting Conversation During Colonoscopy: A Trial on Patient Satisfaction
|
Phase 4 | |
| Active, not recruiting |
NCT02264249 -
Residual Gastric Volume in Same Day Versus Split Dose and Evening Before Bowel Preparation
|
N/A | |
| Completed |
NCT01964417 -
The Comparative Study Between Bowel Preparation Method
|
Phase 3 | |
| Terminated |
NCT01978509 -
The Affect of Low-Volume Bowel Preparation for Hospitalized Patients Colonoscopies
|
N/A | |
| Recruiting |
NCT01685970 -
Comparison of Same-day 2 Sachets Picosulfate Versus High Volume PEG for Afternoon Colonoscopy
|
Phase 3 | |
| Completed |
NCT01518790 -
Short Course, Single-dose PEG 3350 for Colonoscopy Prep in Children
|
N/A | |
| Recruiting |
NCT00748293 -
Achievement of Better Examinee Compliance on Colon Cleansing Using Commercialized Low-Residue Diet
|
N/A | |
| Completed |
NCT00779649 -
MoviPrep® Versus HalfLytely®, Low-VolUme PEG Solutions for Colon Cleansing: An InvesTigator-blindEd, Randomized, Trial
|
Phase 4 | |
| Completed |
NCT00671177 -
Clinical Evaluation of Water Immersion Colonoscopy Insertion Technique
|
N/A | |
| Completed |
NCT00380497 -
Pico-Salax Versus Poly-Ethylene Glycol for Bowel Cleanout Before Colonoscopy in Children
|
Phase 4 | |
| Recruiting |
NCT00160823 -
Impact of a Self-Administered Information Leaflet on Adequacy of Colonic Cleansing for in-Hospital Patients
|
Phase 3 | |
| Completed |
NCT00314418 -
Patient Position and Impact on Colonoscopy Time
|
N/A | |
| Completed |
NCT00390598 -
PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy
|
Phase 2/Phase 3 | |
| Completed |
NCT00427089 -
Comparison of 2L NRL994 With NaP Preparation in Colon Cleansing Prior to Colonoscopies for Colon Tumor Screening
|
Phase 3 | |
| Completed |
NCT00209573 -
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
|
Phase 3 | |
| Completed |
NCT05823350 -
The Effect of Abdominal Massage on Pain and Distention After Colonoscopy
|
N/A |